Clinical Pipeline
Kadmon has built a robust pipeline of therapeutic candidates in all stages of development. Our focus is on serious diseases where there is great need and opportunity for innovative medicines. Our product candidates and development strategies contemplate both immediate possibilities in medicine, such as reducing toxicity or addressing certain disease resistance and mutation, and future possibilities, creating human targeted agents, HTAs, by blocking the metabolomic processes of disease, rendering irrelevant its mechanisms of survival.
